新型神经保护剂TQ0701-2对大鼠脑缺血再灌注损伤的保护作用

目的：研究新型神经保护剂TQ0701-2对大鼠脑缺血再灌注损伤的保护作用。方法：将120只雄性SD大鼠随机分为假手术组、模型组、依达拉奉组（3.0mg/kg）以及TQ0701-2高剂量组（6.0mg/kg）、中剂量组（3.0mg/kg）、低剂量组（1.5mg/kg）。假手术组仅进行手术而不造成缺血状态,其余各组均采用Longa线栓法制备大鼠MCAO模型,在缺血2h后进行再灌注。TQ0701-2三个剂量组和依达拉奉组分别在缺血前30min以及再灌注0、2h尾静脉注射TQ0701-2和依达拉奉,假手术组和模型组则给予等量的生理盐水。再灌注24h后观察大鼠神经功能损伤症状、脑组织梗死率以及病理组织学的改变。结果：模型组大鼠神经功能损伤严重,脑组织梗死率也明显增高（P〈0.01vs假手术组）。与依达拉奉的保护作用相同,TQ0701-2高中低三个剂量均能显著降低MCAO大鼠的神经功能评分和脑组织梗死率（P〈0.01vs模型组）,并且三个剂量的改善作用是随着浓度增大而增强的,具有剂量相关性。另外,TQ0701-2对大鼠脑缺血再灌注所致的神经元变性、坏死也有一定的保护作用。结论：研究表明,依达拉奉衍生物TQ0701-2对大鼠的脑缺血再灌注损伤有明显的神经保护作用。

Protective effect of TQ0701-2 on cerebral ischemia reperfusion injury in rats

AIM:To investigate the protective effect of a new type nerves protectant TQ0701-2,as the derivate of edaravone free radical scavenger,on cerebral ischemia reperfusion injury rat.METHODS:120 male SD rats were randomly divided into sham group,model group,edaravone group(3.0 mg/kg)and TQ0701-2 highdose group(6.0 mg/kg),middle-dose(3.0mg/kg)and low-dose group(1.5 mg/kg).Animals in the latter five groups were subjected to transient focal ischemia by the middle cerebral artery occlusion(MCAO)for 2 h before reperfusion,while the sham group wasn't ischemic.The rats were injected with edaravone or TQ0701-2 30 min before ischemic and 0 min,2 h after reperfusion in edaravone and TQ0701-2 groups,sham group and model group were treated with normal saline as well.After 24 h of reperfusion,the infarct ratio,neurological and histological deficient and the changes of pathohistology were evaluated.RESULTS:The infarct ratios and neurological deficit scores in the model group were increased(P＜0.01 vs.sham group).The neurological deficit scores and infarct ratios in three doses of TQ0701-2 were significantly decreased(P＜0.01 vs.model group),similar to edaravone,and the protection was enhanced in a dose-dependent manner.Moreover,TQ0701-2improved neuronal degeneration and necrosis induced by ischemia reperfusion.CONCLUSION:These results show that the the derivate of edaravone TQ0701-2 has notable protective effect on cerebralischemia reperfusion injury in rats.